Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · IEX Real-Time Price · USD
0.700
-0.026 (-3.59%)
Mar 28, 2024, 10:39 AM EDT - Market open

Phio Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2010
Net Income
-11.48-13.29-8.79-8.91-7.36-12.45-11.07-10.43-12.93-29.54
Upgrade
Depreciation & Amortization
0.190.190.180.180.080.070.050.080.090.1
Upgrade
Share-Based Compensation
0.410.480.140.30.280.310.761.541.851.98
Upgrade
Other Operating Activities
-1.260.76-0.33-0.21-0.522.550.431.29-0.8912.54
Upgrade
Operating Cash Flow
-12.13-11.86-8.8-8.65-7.52-9.51-7.76-7.32-7.76-6.31
Upgrade
Capital Expenditures
-0.12-0.05-0.02-0.07-0.01-0.2-0-0.06-0.08-0.08
Upgrade
Acquisitions
000000.10000
Upgrade
Change in Investments
0000005.35-5.53-3
Upgrade
Other Investing Activities
----------0.02
Upgrade
Investing Cash Flow
-0.12-0.05-0.02-0.07-0.01-0.15.35-5.562.92-3.09
Upgrade
Share Issuance / Repurchase
021.7215.930.7818.820.2910.29.31.9515.67
Upgrade
Debt Issued / Paid
000.2-0.0100000-0.01
Upgrade
Other Financing Activities
-0.03-0-0-0---0.2--
Upgrade
Financing Cash Flow
-0.0321.7216.130.7718.820.2910.29.51.9515.67
Upgrade
Net Cash Flow
-12.289.817.31-7.9511.3-9.337.79-3.38-2.896.26
Upgrade
Free Cash Flow
-12.25-11.91-8.82-8.72-7.53-9.72-7.76-7.37-7.84-6.39
Upgrade
Free Cash Flow Margin
----41509.52%-5452.90%-64780.00%-40863.16%-21688.24%-11043.66%-1601.25%
Upgrade
Free Cash Flow Per Share
-10.78-11.14-23.07-227.00-705.00-2840.53-7595.89-9791.70-31626.88-41083.12
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).